glp 1 drugs long term effects GLP-1 medication side for diabetes and weight loss Exploring the Side Effects of

Tirzepatide displayed an unprecedented glucose and body weight lowering potential, presenting also with the ability to increase insulin sensitivity, reduce systolic blood pressure and inflammation and ameliorate dyslipidemia, particularly by reducing triglycerides levels

Curious about Microdosing GLP-1

Designed for those who want results without the hassle, these patches gently release GLP-1 to help manage appetite and boost metabolism, making it easier t

With Lemon Flavonoids, Berberine, Functional Mushrooms, Nootropics & B Vitamins Improve Fitness while Boosting Mood & Energy

The global incretin-based drugs market was valued at USD 39.4 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 72.6 billion by 2035, expanding at a CAGR of 6.4% between 2026 and 2035, driven by the rising prevalence of type 2 diabetes mellitus.

Glucagon-like peptide-1 (GLP-1) receptor agonists are a newer class of diabetes drugs that have the potential to double as weight loss drugs, widening their lucrative market potentials